A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2009

Altmetric Badge

Mentioned by

patent: 20 patents

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 31 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 20 patents that reference this research output.

Antibodies and chimeric antigen receptors specific for CD19

Grant US-11827714-B2

United States of America

Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in…

Grant US-11634488-B2

United States of America

Antibodies to the C3D fragment of complement component 3

Grant US-RE49339-E1

United States of America

Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile

Grant US-RE49192-E1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 16 additional patents.